Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Revenue | 400M | 310M |
| Cost of revenue | 5M | 3M |
| Research and development | 275M | 222M |
| Selling, general and administrative | 165M | 156M |
| Operating income | −45M | −70M |
| Pre-tax income | −19M | −53M |
| Income tax | 16M | −2M |
| Net income | −36M | −51M |
| Earnings per share | −0.71 | −1.02 |
| Earnings per share, diluted | −0.71 | −1.02 |
| Weighted average shares | 50M | 50M |
| Weighted average shares, diluted | 50M | 50M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 453M | 468M | 498M | 488M | 477M | 456M | 538M | 505M |
| Short-term investments | 392M | 396M | 394M |
| Metric | 31/12/2025 | 31/12/2024 |
|---|---|---|
| Operating cash flow | −11M | 26M |
| Depreciation and amortisation | 3M | 4M |
| Share-based compensation | 38M | 34M |
| Capital expenditure | 4M | 5M |
| Investing cash flow | −16M | −355M |
| Financing cash flow | 12M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 395M |
| 360M |
| 365M |
| 364M |
| 355M |
| Receivables | — | — | — | — | — | 63M | 64M | 60M |
| Inventory | 8M | 7M | 6M | 5M | 7M | 5M | 5M | 3M |
| Current assets | 1.00B | 997M | 1.02B | 1.00B | 949M | 930M | 1.01B | 957M |
| Property, plant and equipment | 12M | 11M | 9M | 10M | 10M | 10M | 9M | 8M |
| Total assets | 1.07B | 1.07B | 1.10B | 1.08B | 1.03B | 1.01B | 1.08B | 1.02B |
| Current liabilities | 240M | 247M | 170M | 170M | 149M | 212M | 266M | 185M |
| Total liabilities | 678M | 686M | 706M | 694M | 650M | 649M | 707M | 664M |
| Equity | 394M | 381M | 397M | 388M | 378M | 361M | 378M | 359M |
| Shares outstanding | 51M | 51M | 50M | 50M | 50M | 50M | 50M | 50M |
| Shares issued | 51M | 51M | 50M | 50M | 50M | 50M | 50M | 50M |
| 344M |